Abstract
Objective: To study immunologic character of tumor-infiltrating lymphocytes (TIL) on postin vitro expansion in ovarian carcinoma, and evaluate the prospects by adopting TIL treatment of ovarian carcinoma at an advanced stage. Methods: Cellular phenotype changes in TIL were analyzed by flow cytometry. By means of molecular biology and immunologic methods, ability to secrete cytokines and anti-tumor activities of in TIL was studied. Results: Difference of cellular phenotypes in TIL was probably related to the type, feature and resource of the tumor. TIL obtained from phoroplast and parenchyma was dominant in CD3+CD4+. TIL obtained from tumor tissues, around microvessels and ascitic fluid was dominant in CD3+CD8 Concentration of rIL-2in vitro played a significant role in immunologic character of TIL. By means of rIL-2 expansionin vitro, TIL has apparently been improved in competence of secreting some cytokines, such as IL-2, TNF-α, IFN-γ, and anti-tumor activities. The activated TIL was more stimulated by further adding anti-CD3 or PHA (suitable concentration), which significantly increased its ability to secrete cytokines. Treatment with TIL+CTX or TIL+ rIL-2, could apparently improve phenotypes in peripheral blood of patients, with definitive effects. Conclusion: Immunologic activities of TILin vitro are apparently improved by rIL2 expansion. Regression of tumor, by means of infusion TIL, is not largely attributed to direct cytotoxicity to tumor cells, but indirectly and partly augmenting cellular activities and abilities of immunomodulation in patients with ovarian carcinoma being dependent on secreting multiple cytokines.
Similar content being viewed by others
References
Li BR, Shen DH. Preliminary study on biological characters of tumor-infiltrating lymphocytes. Chin J Microbiol Immunol 1994; 12: 14.
Wang JH, Tong XQ, Jiang J, et al. Some cytokine gene expression of tumor-infiltrating lymphocytes in ovarian carcinoma. Chin J Cancer Biotherapy 1999; 1: 39.
Heo DS, Thresal, Jonas T, et al. Long-term IL-2 dependent cytotoxic activity of TILs from human squamous cell carcinoma of the head and neck. Cancer Res 1987; 47: 6353.
Yang TB, Ying XL. Practical Immunity. 1st ed. Jilin: Changchun Press 1994; 591–599.
Hu BY, Zhang BZ, Zhu YM, et al. Measure of inducible TNF in whole blood. Shanghai J Immunol 1991; 11:3.
J. Sambrook E, F fritsh, T Maniatis edit (**g TY, et al. Translating). Molecular Cloning. 2nd ed. Bei**g: Bei**g Science press, 1993; 880–915.
Hirokazu I, kazuyuki FU, Koucichi TK, et al. Immunonodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltration lymphocytes. Cancer Res 1994; 54: 190.
Hirokazu I, Kazuyyuki FU, Koucichi TK, et al. Immunonodulation on patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltration lymphocytes. Cancer Res 1994; 54: 190.
George EP, Deric DS, Valeric RA, et al. T-cell recognition of ovarian cancer. Surg 1993; Feb: 11.
Freedman RS, Tomasovic B, Templin S, et al. Large scale expansion in interleukin-2 of tumor-infiltrating-lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods 1994; 167: 145.
Wang JH, Tong XQ, Ding JQ, et al. Study on the multiple cytokine gene expression on ovarian carcinoma cells. Shanghai J Immunol 1998; 6: 334.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the National Natural Science Foundation of China (No.39370706).
Rights and permissions
About this article
Cite this article
Wang, Jh., Tong, Sq., Li, Br. et al. Immunologic character of tumor infiltrating lymphocytes in ovarian carcinoma. Chin J Cancer Res 12, 99–104 (2000). https://doi.org/10.1007/BF02983432
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02983432